Merck Q2 Earnings in the Cards: Buy, Sell or Hold Ahead of Results?

• click to rate

  Posted by Two Blokes Jul 25 - Filed in Stock - 2 views
  
  MRK is gearing up to report Q2 earnings. While Keytruda drives growth, there are concerns over Gardasil's China sales, generics and pipeline depth.